Oral oncology
Safety reporting in head and neck squamous cell carcinoma clinical Trials: A comparative analysis of ClinicalTrials.gov data and published research.
Mahad Chaudhry, Annes Elfar, Kaylyn Rowsey, Andrew Neel, Adam Khan, Ty Lutze, David Wenger, Matt Vassar
Published: 202510.1016/j.oraloncology.2025.107840
Abstract
INTRODUCTION: Head and Neck Squamous Cell Carcinoma (HNSCC) is a debilitating malignancy that requires a multimodal approach in treatment, which is associated with a considerable burden of adverse events (AE). Since the 2007 FDA Amendments Act (FDAAA…
Preview only. Read the full abstract at the source